The Covid-19 Vaccine Production Club : Will Value Chains Temper Nationalism?

The Covid-19 Vaccine Production Club : Will Value Chains Temper Nationalism?

In the first two months of 2021, the production of COVID-19 vaccines has suffered setbacks delaying the implementation of national inoculation strategies. These delays have revealed the concentration of vaccine manufacture in a small club of produc...

Full description

Bibliographic Details
Main Authors: Evenett, Simon J., Hoekman, Bernard, Rocha, Nadia, Ruta, Michele
Format: Working Paper
Language:English
Published: World Bank, Washington, DC 2021
Subjects:
CORONAVIRUS
COVID-19 VACCINATION
VALUE CHAIN
VACCINE NATIONALISM
EXPORT CONTROL
EXPORT BAN
mRNA
LIPIDS
NITRILE GLOVE
SYRINGE
VIAL
VACCINE PRODUCTION
Online Access:http://documents.worldbank.org/curated/en/244291614991534306/The-Covid-19-Vaccine-Production-Club-Will-Value-Chains-Temper-Nationalism
http://hdl.handle.net/10986/35244
id okr-10986-35244
recordtype oai_dc
spelling okr-10986-352442022-09-20T00:08:50Z The Covid-19 Vaccine Production Club : Will Value Chains Temper Nationalism? Evenett, Simon J. Hoekman, Bernard Rocha, Nadia Ruta, Michele CORONAVIRUS COVID-19 VACCINATION VALUE CHAIN VACCINE NATIONALISM EXPORT CONTROL EXPORT BAN mRNA LIPIDS NITRILE GLOVE SYRINGE VIAL VACCINE PRODUCTION In the first two months of 2021, the production of COVID-19 vaccines has suffered setbacks delaying the implementation of national inoculation strategies. These delays have revealed the concentration of vaccine manufacture in a small club of producer nations, which in turn has implications for the degree to which cross-border value chains can deter more aggressive forms of Vaccine Nationalism, such as export curbs. This paper documents the existence of this club, taking account of not just the production of final vaccines but also the ingredients of and items needed to manufacture and distribute COVID-19 vaccines. During 2017–19, vaccine producing nations sourced 88 percent of their key vaccine ingredients from other vaccine producing trading partners. Combined with the growing number of mutations of COVID-19 and the realization that this coronavirus is likely to become a permanent endemic global health threat, this finding calls for a rethink of the policy calculus towards ramping up the production and distribution of COVID-19 vaccines, its ingredients, and the various items needed to deliver them. The more approved vaccines that are safely produced, the smaller will be the temptation to succumb to zero-sum Vaccine Nationalism. 2021-03-11T14:20:07Z 2021-03-11T14:20:07Z 2021-03 Working Paper http://documents.worldbank.org/curated/en/244291614991534306/The-Covid-19-Vaccine-Production-Club-Will-Value-Chains-Temper-Nationalism http://hdl.handle.net/10986/35244 English Policy Research Working Paper;No. 9565 CC BY 3.0 IGO http://creativecommons.org/licenses/by/3.0/igo World Bank World Bank, Washington, DC Publications & Research Publications & Research :: Policy Research Working Paper
repository_type Digital Repository
institution_category Foreign Institution
institution Digital Repositories
building World Bank Open Knowledge Repository
collection World Bank
language English
topic CORONAVIRUS
COVID-19 VACCINATION
VALUE CHAIN
VACCINE NATIONALISM
EXPORT CONTROL
EXPORT BAN
mRNA
LIPIDS
NITRILE GLOVE
SYRINGE
VIAL
VACCINE PRODUCTION
spellingShingle CORONAVIRUS
COVID-19 VACCINATION
VALUE CHAIN
VACCINE NATIONALISM
EXPORT CONTROL
EXPORT BAN
mRNA
LIPIDS
NITRILE GLOVE
SYRINGE
VIAL
VACCINE PRODUCTION
Evenett, Simon J.
Hoekman, Bernard
Rocha, Nadia
Ruta, Michele
The Covid-19 Vaccine Production Club : Will Value Chains Temper Nationalism?
relation Policy Research Working Paper;No. 9565
description In the first two months of 2021, the production of COVID-19 vaccines has suffered setbacks delaying the implementation of national inoculation strategies. These delays have revealed the concentration of vaccine manufacture in a small club of producer nations, which in turn has implications for the degree to which cross-border value chains can deter more aggressive forms of Vaccine Nationalism, such as export curbs. This paper documents the existence of this club, taking account of not just the production of final vaccines but also the ingredients of and items needed to manufacture and distribute COVID-19 vaccines. During 2017–19, vaccine producing nations sourced 88 percent of their key vaccine ingredients from other vaccine producing trading partners. Combined with the growing number of mutations of COVID-19 and the realization that this coronavirus is likely to become a permanent endemic global health threat, this finding calls for a rethink of the policy calculus towards ramping up the production and distribution of COVID-19 vaccines, its ingredients, and the various items needed to deliver them. The more approved vaccines that are safely produced, the smaller will be the temptation to succumb to zero-sum Vaccine Nationalism.
format Working Paper
author Evenett, Simon J.
Hoekman, Bernard
Rocha, Nadia
Ruta, Michele
author_facet Evenett, Simon J.
Hoekman, Bernard
Rocha, Nadia
Ruta, Michele
author_sort Evenett, Simon J.
title The Covid-19 Vaccine Production Club : Will Value Chains Temper Nationalism?
title_short The Covid-19 Vaccine Production Club : Will Value Chains Temper Nationalism?
title_full The Covid-19 Vaccine Production Club : Will Value Chains Temper Nationalism?
title_fullStr The Covid-19 Vaccine Production Club : Will Value Chains Temper Nationalism?
title_full_unstemmed The Covid-19 Vaccine Production Club : Will Value Chains Temper Nationalism?
title_sort covid-19 vaccine production club : will value chains temper nationalism?
publisher World Bank, Washington, DC
publishDate 2021
url http://documents.worldbank.org/curated/en/244291614991534306/The-Covid-19-Vaccine-Production-Club-Will-Value-Chains-Temper-Nationalism
http://hdl.handle.net/10986/35244
_version_ 1764482629052137472

Similar Items